Vallon Pharmaceuticals Presents Positive Data from Proof-of-Concept Intranasal Human Abuse Study of Its Investigational ADHD Stimulant, ADAIR Results demonstrated that ADAIR had slower absorption and lower early exposure, and was less desirable to recreational drug abusers on key measures of abuse liability compared to commercially...

Widely Prescribed Stimulants and the Risk of Psychosis in Young People with ADHD - A Free Webinar from the Brain & Behavior Research Foundation New York, July 07, 2020 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Widely Prescribed Stimulants and the Risk of Psychosis in Young People with ADHD”...

Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall® NORTHVALE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today that it has entered into a license, supply, and distribution...

Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall® NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...

TheRecover.com Provides a List of Adderall Side effects SAN DIEGO, April 08, 2018 (GLOBE NEWSWIRE) -- Adderall is a drug often prescribed for majorities, especially in well developed countries, and these drugs are such that they possess a lot of side...